A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/1998
10/22/1998	CA2286461A1 Controlled dissolution cross-linked protein crystals
10/22/1998	CA2286079A1 Cefadroxil monohydrate tablet formulation
10/22/1998	CA2286078A1 Novel compounds
10/22/1998	CA2285572A1 A method for treating papillomavirus infections
10/22/1998	CA2283511A1 Teicoplanin derivatives
10/22/1998	CA2283435A1 Deacylation process and product
10/22/1998	CA2234399A1 Cdna clone hmtmf81 that encodes a novel human 7-transmembrane receptor
10/22/1998	CA2231740A1 Cdna clone hmtmf81 that encodes a novel human 7-transmembrane receptor
10/22/1998	CA2229428A1 3-dehydroquinate synthase (arob)
10/21/1998	EP0872556A2 Process for the preparation of moenomycin A
10/21/1998	EP0872553A1 Chimeric and/or growth-restricted flaviviruses
10/21/1998	EP0872550A2 cDNA clone HACCH94 that encodes a human 7-transmembrane receptor
10/21/1998	EP0872478A2 Intermediates for the preparation of 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
10/21/1998	EP0872237A1 Method and compositions for the synthesis of BCH-189 and related compounds
10/21/1998	EP0871756A2 High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations
10/21/1998	EP0871755A1 Vectors for gene delivery
10/21/1998	EP0871738A1 Viral recombinant pseudo-particles and vaccinal and anti-tumoral applications
10/21/1998	EP0871735A1 Therapeutic and diagnostic compositions
10/21/1998	EP0871721A1 A protein-lipid conjugate, consisting of heparin binding protein (hbp) and a ceramide analogue, and its pharmaceutical use in treatment of conditions involving stress injury to cells
10/21/1998	EP0871672A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
10/21/1998	EP0871654A1 Protegrins
10/21/1998	EP0871645A1 Modulators of the function of fas/apo1 receptors
10/21/1998	EP0871639A1 Novel orthosomycins from micromonospora carbonacea
10/21/1998	EP0871638A1 Novel aminooligosaccharide derivative and process for preparing the same
10/21/1998	EP0871635A1 Isomerisation process
10/21/1998	EP0871632A1 Production of a crystalline salt of amoxicillin
10/21/1998	EP0871628A1 Quinolizinone type compounds
10/21/1998	EP0871625A1 Preparation of triazoles by organometallic addition to ketones and intermediates therefor
10/21/1998	EP0871619A1 Phenyl thiazole derivatives with anti herpes virus properties
10/21/1998	EP0871606A1 New compounds and their compositions having anti-inflammatory and anti-thrombotic activities
10/21/1998	EP0871490A1 Branched hydrazone linkers
10/21/1998	EP0871487A1 Dendritic cell stimulatory factor
10/21/1998	EP0871485A1 COMPOSITIONS AND METHODS FOR CATALYZING HYDROLYSIS OF HIV gp120
10/21/1998	EP0871482A1 Recombinant vesiculoviruses and their uses
10/21/1998	EP0871469A1 Nisin in combination with glycerol monolaurate active against helicobacter
10/21/1998	EP0871465A1 Use of ritonavir (abt-538) for improving the pharmacokinetics of drugs metabolized by cytochrome p450 in a method of treating aids
10/21/1998	EP0871460A1 Bioactive factors of aloe vera plants
10/21/1998	EP0871444A1 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use
10/21/1998	EP0871439A1 Substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl) hydroxamic acid compounds
10/21/1998	EP0871363A1 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria
10/21/1998	EP0752871A4 Adhesion inhibiting composition
10/21/1998	EP0586438B1 Hepatitis a virus production
10/21/1998	CN1196732A Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
10/21/1998	CN1196678A Di-and trivalent small molecule selecting protein inhibitors
10/21/1998	CN1196390A Chicken Marek's disease virus genic mutant strain and its application
10/21/1998	CN1196356A Process for preparation of moenomycin A
10/21/1998	CN1040321C Pyran-2-ones and 5,6-dihydropyran-2-ones, medicine composition containing them and pharmacy use thereof
10/20/1998	US5824805 Branched hydrazone linkers
10/20/1998	US5824788 Cloning of gene encoding the GP28.5 protein of toxoplasma gondii; peptide fragments of said protein and their applications
10/20/1998	US5824784 Genetic engineering with polypeptides and proteins
10/20/1998	US5824777 Isolated amino acid sequences of the complete cdna sequence coded by the rna genome of the aik-c strain
10/20/1998	US5824774 Chimeric isoprenoid synthases and uses thereof
10/20/1998	US5824698 Staphylococcus, enterococcus or heliobacter
10/20/1998	US5824696 Medicaments
10/20/1998	US5824688 HIV protease inhibitors
10/20/1998	US5824687 Pyridinium salts and their use for the control of helicobacter bacteria
10/20/1998	US5824551 Method for modulating cell apoptosis
10/20/1998	US5824519 A dna sequence comprising a specific binding promoter encoding a ribozyme as antitumor agents, viricides, antiproliferative agents; drug delivery
10/20/1998	US5824508 Dna and amino acid sequences, vectors and host cells
10/20/1998	US5824504 Polynucleotides
10/20/1998	US5824307 Human-murine chimeric antibodies against respiratory syncytial virus
10/20/1998	US5824305 Bromelain protease of amino acid sequences as bactericides,anticarcinogenic agents, antiinflammatory agents or atherosclerosis
10/20/1998	US5824304 Peripheralization of hematopoietic stem cells
10/17/1998	CA2234778A1 A process for the preparation of moenomycin a
10/15/1998	WO1998045712A2 20 human secreted proteins
10/15/1998	WO1998045415A1 Method for inactivating a virus
10/15/1998	WO1998045335A1 N-sulphated hyaluronic acid compounds, derivatives thereof and a process for their preparation
10/15/1998	WO1998045330A1 Antiviral protease inhibitors
10/15/1998	WO1998045325A1 Peptides useful for reducing symptoms of toxic shock syndrome
10/15/1998	WO1998045323A1 Synthetic peptides useful in biological assays for detecting infections caused by group o hiv-1 viruses
10/15/1998	WO1998045314A1 Composition and method for treatment of cmv infections
10/15/1998	WO1998045300A1 A process for the preparation of a metal salt of clavulanic acid
10/15/1998	WO1998045299A1 Crystalline amine salt of cefdinir
10/15/1998	WO1998045294A1 Compounds
10/15/1998	WO1998045278A1 Asymmetric synthesis of benzoxazinones via new intermediates
10/15/1998	WO1998045276A2 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinones useful as hiv reverse transcriptase inhibitors
10/15/1998	WO1998045275A1 Compounds and compositions for treating diseases associated with serine protease, particularly tryptase, activity
10/15/1998	WO1998045269A1 Quinoline derivatives, having in particular antiviral properties, preparation and biological applications thereof
10/15/1998	WO1998045268A1 Nicotinamide derivatives
10/15/1998	WO1998045259A2 Polyaromatic antiviral compositions
10/15/1998	WO1998045253A1 Activated iododerivatives for the treatment of cancer and aids
10/15/1998	WO1998044944A2 Stabilized human papillomavirus formulations
10/15/1998	WO1998044926A1 Antimicrobial compositions
10/15/1998	WO1998044913A2 Compositions containing mkc-442 in combination with other antiviral agents
10/15/1998	WO1998017810A3 Multi-functional chimeric hematopoietic receptor agonists
10/15/1998	DE19715504A1 PMMA-Membranen mit Polyethylenglykol-gekoppelten Wirksubstanzen PMMA membranes with polyethylene glycol-coupled active substances
10/15/1998	CA2286690A1 Method for inactivating a virus
10/15/1998	CA2286346A1 Peptides useful for reducing symptoms of toxic shock syndrome
10/15/1998	CA2286303A1 20 human secreted proteins
10/15/1998	CA2286294A1 Stabilized human papillomavirus formulations
10/15/1998	CA2286186A1 Activated iododerivatives for the treatment of cancer and aids
10/15/1998	CA2285577A1 Compositions containing mkc-442 in combination with other antiviral agents
10/15/1998	CA2285454A1 Compounds and compositions for treating diseases associated with serine protease, particularly tryptase, activity
10/15/1998	CA2285388A1 Compounds
10/15/1998	CA2285287A1 Antiviral protease inhibitors
10/15/1998	CA2285000A1 Asymmetric synthesis of benzoxazinones via new intermediates
10/15/1998	CA2284996A1 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinones useful as hiv reverse transcriptase inhibitors
10/15/1998	CA2283718A1 Crystalline amine salt of cefdinir
10/15/1998	CA2257500A1 Antimicrobial compositions
10/15/1998	CA2232861A1 Cdna clone hacch94 that encodes a novel human 7-transmembrane receptor

1 ... 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 1555 ... 1798